DOI QR코드

DOI QR Code

Ceriporia lacerata 균사체 배양물의 혈당 강하 활성 평가

Hypoglycemic effects of submerged culture of Ceriporia lacerata mycelium

  • 투고 : 2015.01.14
  • 심사 : 2015.01.29
  • 발행 : 2015.02.28

초록

세리포리아 락세라타 균사체 배양물(CL01)의 혈당 강하 효과를 확인하기 위해 in-vitro 및 in-vivo 시험을 수행하였다. CL01이 INS-1 세포에서 덱사메타손에 의한 세포 사멸 방지 효과를 나타냈으며 3T3-L1 세포에서는 당수송체인 GLUT4의 발현을 증가시켰다. 제 2형 당뇨 마우스를 4 그룹(normal control (G1), negative control (G2), positive control (G3), CL01 250 mg/kg (G4))으로 나누어 6주간 매일 CL01을 투여한 후 혈중 지표를 확인한 결과, CL01 섭취군은 체중, 사료 및 물 섭취량에서 음성대조군 대비 유의적인 차이를 보이지 않았다. 투여 5주 후 CL01 섭취군의 혈당이 음성대조군 대비 유의적인 감소를 보였으며 6주 경과 시 혈중 인슐린은 36% 증가하였고 혈중 C-peptide 농도는 18% 감소하였다. 경구 당 부하 시험 결과 CL01 섭취군의 혈당이 음성대조군 대비 15% 감소하였다. 이상의 결과를 통해 CL01이 베타 세포를 증식시켜 인슐린 분비를 촉진하고 혈당을 낮추는 효과가 있음을 알 수 있다.

To investigate the hypoglycemic effect of the submerged culture of the Ceriporia lacerata mycelium (CL01) species, in-vitro and in-vivo tests were executed using INS-1 and 3T3-L1 cells, normal and diabetic mice. CL01 exhibited an inhibitory effect on cell death through dexamethasone in the INS-1 cells, and increased the GLUT4 expression in the 3T3-L1 cells. A hematological monitoring test was executed using diabetic mice divided into four groups : normal control (G1), negative control (G2), positive control (G3), and CL01 250 mg/kg (G4) groups, which were fed daily for 6 weeks. The body weight gain, food intake, and water intake of G4 were not significantly different from those of G2. After 5 weeks, the blood glucose levels of G4 were significantly different from those of G2. After 6 weeks, the plasma insulin levels of G4 increased by about 36% compared to those of G2, and the plasma C-peptide levels of G4 were lower by about 18%. than those of G3. The results of the oral glucose tolerance test (OGTT) showed that CL01 lessened the blood glucose levels of G4 by 15% compared to G2. It was concluded that CL01 stimulates the proliferation of beta cells and promotes insulin secretion and may thus have a potential in improving the hypoglycemic effects among the diabetic symptoms.

키워드

참고문헌

  1. Beckman JA, Creager MA, Lbby P (2002) Diabetes and atherosclerosis : epidermiology, pathophysiology, and management. JAMA, 287, 2570-2581 https://doi.org/10.1001/jama.287.19.2570
  2. Fonseca V (2006) The role of basal insulin therapy in patients with type 2 diabetes mellitus. Insulin, 1, 51-60 https://doi.org/10.1016/S1557-0843(06)80010-2
  3. Korean Statistical Association (2013) Annual report on the cause of death statistics. Korean Statistical Association, Seoul, Korea
  4. Friedman JM (2003) A war on obesity, not the obese. Science, 299, 856-858 https://doi.org/10.1126/science.1079856
  5. Hwang KY, Kim YH, Cho YS, Park YS, Lee JY, Kang KD, Kim K, Joo DK, Seong SI (2008) Hypoglycemic effect of fermented soybean culture mixed with mulberry leaves on neonatal streptozotocin-induced diabetic rats. J Korean Soc Food Sci Nutr, 37, 452-458 https://doi.org/10.3746/jkfn.2008.37.4.452
  6. Wani BA, Bodha RH, Wani AH (2010) Nutritional and medicinal importance of mushrroms. J Med Plants Res, 4, 2598-2604
  7. Yu HE, Cho SM, Seo GS, Lee BS, Lee DH, Lee JS (2006) Screening of bioactive compounds from mushroom Pholiota sp. Korea J Mycol, 34, 15-21 https://doi.org/10.4489/KJM.2006.34.1.015
  8. Lee YS, Kim JB, Shin SR, Kim NW (2006) Analysis of nutritional components of Lepista nuda. Korean J Food Preserv, 13, 375-381
  9. Kim BK, Shin GG, Jeon BS, Cha JY (2001) Cholesterol-lowering effect of mushrooms powder in hyperlipidemic rats. Korean J Food Sci Nutr, 30, 510-515
  10. Hong JS, Kim YH, Kim MK, Kim YS, Sohn HS (1989) Contents of free amino acids and total amino acids in Agaricus bisporus, Plerotus ostreatus and Lentinus edodes. Korean J Food Sci Technol, 21, 58-62
  11. Ma SJ (1983) Effects of the substances extracted from dried mushroom by several organic solvents on the stability of fat. J Food Sci, 15, 150-154
  12. Tang YJ, Zhu LW, Li HM, Li DS (2007) Submerged culture of mushrooms in bioreactors-challenges, current state-of-the art, and future prospects. Food Technol Biotechnol, 45, 221-229
  13. Lee YS, Kim JB, Shin SR, Kim NW (2006) Analysis of nutritional components of Lepista nuda. Korean J Food Preserv, 13, 375-381
  14. Shon MY, Seo KI, Choi SY, Sung NJ, Lee SW, Park SK (2006) Chemical compounds and biological activity of Phellinus baumii. J Korean Soc Food Sci Nutr, 35, 524-529 https://doi.org/10.3746/jkfn.2006.35.5.524
  15. Song TY, Yen GC (2002) Antioxidant properties of Antrodia camphorata in submerged culture. J Agric Food Chem, 50, 3322-3327 https://doi.org/10.1021/jf011671z
  16. Sugihara TF, Humfeld H (1954) Submerged culture of the mycelium of various species of mushroom. Appl Microbiol, 2, 170-172
  17. Lee JW, Gwak KS, Park JY, Park MJ, Choi DH, Kwon M, Choi IG (2007) Biological pretreatment of softwood Pinus densiflora by three white rot fungi. J Microbiol, 45, 485-491
  18. Choi SJ, Yeon SL, Kim JK, Kim JK, Lim SS (2010) Physiological activities of extract from edible mushrooms. J Korean Soc Food Sci Nutr, 39, 1087-1096 https://doi.org/10.3746/jkfn.2010.39.8.1087
  19. Tsunda A, Ishida N (1970) A mushroom extracts as an interferon inducer. Ann NY Acad Sci, 173, 719-726 https://doi.org/10.1111/j.1749-6632.1970.tb53464.x
  20. Wasser SP (2002) Medical mushrooms as source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol, 60, 258-274 https://doi.org/10.1007/s00253-002-1076-7
  21. Kim JY, Moon KD, Lee SD, Cho SH, Kang HI, Lee ST, Seo KI (2004) Physicochemical properties of Pleurotus eryngii. J Korean Food Preserv, 11, 347-351
  22. Lin Y, He X, Han G, Tian Q, Hu W (2011) Removal of crystal violet from aqueous solution using powdered mycelia biomass of Ceroporia lacerata P2. J Environ Sci, 23, 2055-2062 https://doi.org/10.1016/S1001-0742(10)60643-2
  23. Park JY (2007) Biodegradation of dimethyl phthalate by white rot fungus, Ceriporia lacerata. MS thesis, Seoul National University, Seoul, Korea
  24. Kim JE, Kim HJ, Lee SP (2012) Hyperglycemic effect of submerged culture extract of Ceriporia lacerata in streptozotocin-induced diabetic rats. Food Sci Biotechnol, 21, 1685-1693 https://doi.org/10.1007/s10068-012-0224-9
  25. Roma LP, Bosqueiro JR, Cunha DA, et al (2009) Protection of insulin-producing cells against toxicity of dexamethasone by catalase overexpression. Free Radic Biol Med, 47, 1386-1393 https://doi.org/10.1016/j.freeradbiomed.2009.08.010
  26. Wyllie AH, Kerr JF, Currie AR (1980) Cell death : the significance of apoptosis. Int Rev Cytol, 68, 251-306 https://doi.org/10.1016/S0074-7696(08)62312-8
  27. Allen RT, Hunter WJ III, Agrawal DK (1997) Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods. 37, 215-228 https://doi.org/10.1016/S1056-8719(97)00033-6
  28. Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, Yuan CL, Krokowski D, Wang S, Hatzoglou M, Kilberg MS, Sartor MA, Kaufman RJ (2013) ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol, 15, 481-490 https://doi.org/10.1038/ncb2738
  29. Kang KA, Wang Zhang R, Piao MJ, Kim KC, Kang SS, Kim YW, Lee J, Park D, Hyun JW (2010) Myricetin protects cells against oxidative stress-induced apoptosis via regulation of PI3K/Akt and MAPK signaling pathway. Int J Mol Sci, 11, 4348-4360 https://doi.org/10.3390/ijms11114348
  30. Jung CY, Lee W (1999) Glucose transporters and insulin action; some insights into diabetes management. Arch Pharm Res, 22, 329-334 https://doi.org/10.1007/BF02979053
  31. Hwang HS, Kim HA, Lee SH (2009) Anti-obesity and antidiabetic effects of deep sea water on ob/ob mice. Mar Biotechnol, 11, 531-539 https://doi.org/10.1007/s10126-008-9171-0
  32. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 329, 977-986 https://doi.org/10.1056/NEJM199309303291401
  33. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas of insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 352, 837-853 https://doi.org/10.1016/S0140-6736(98)07019-6
  34. Jung UJ, Lee MK, Jeong KS, Choi MS (2004) The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J Nutr, 134, 2499-2503
  35. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1990) Cardiovascular risk factors in confirmed pre-diabetic individuals : does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA, 263, 2893-2898 https://doi.org/10.1001/jama.1990.03440210043030
  36. Kim JS, Park KS and Lee YY (1998) Characteristic of insulin resistance in Korea. Diabetes, 22, 84-91
  37. Kunar S, Peter MC, Stephen RD (2003) Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol, 284, 1138-1144 https://doi.org/10.1152/ajprenal.00315.2002
  38. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stepens TW, Nyce MR, Ohannesia JP, Marco CC, McKee LJ, Bauer TL (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med, 334, 292-295 https://doi.org/10.1056/NEJM199602013340503

피인용 문헌

  1. Effect of Submerged Culture of Ceriporia lacerata Mycelium on Insulin Signaling Pathway in 3T3-L1 Cell vol.26, pp.3, 2016, https://doi.org/10.5352/JLS.2016.26.3.325
  2. Effect of submerged culture of Ceriporia lacerata mycelium on GLUT4 protein in db/db mouse vol.22, pp.6, 2015, https://doi.org/10.11002/kjfp.2015.22.6.893